Related references
Note: Only part of the references are listed.Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator
Sekhar Surapaneni et al.
DRUG METABOLISM AND DISPOSITION (2021)
Evaluation of species differences in the metabolism of the selective NaV1.7 inhibitor DS-1971a, a mixed substrate of cytochrome P450 and aldehyde oxidase
Daigo Asano et al.
XENOBIOTICA (2021)
Prediction of Metabolite-to-Parent Drug Exposure: Derivation and Application of a Mechanistic Static Model
Ernesto Callegari et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Discovery of DS-1971a, a Potent, Selective NaV1.7 Inhibitor
Tsuyoshi Shinozuka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity
Babiker M. El-Haj et al.
MOLECULES (2020)
Drug-Drug Interaction Risk Assessment of Esaxerenone as a Perpetrator by In Vitro Studies and Static and Physiologically Based Pharmacokinetic Models
Makiko Yamada et al.
DRUG METABOLISM AND DISPOSITION (2020)
Direct and quantitative evaluation of the major human CYP contribution (fmCYP) to drug clearance using the in vitro Silensomes™ model
Yannick Parmentier et al.
XENOBIOTICA (2019)
A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the Metabolites in Safety Testing Regulatory Guidance
Simone Schadt et al.
DRUG METABOLISM AND DISPOSITION (2018)
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical Development
Jim Zheng et al.
DRUG METABOLISM AND DISPOSITION (2018)
Predicting mammalian metabolism and toxicity of pesticides in silico
Robert D. Clark
PEST MANAGEMENT SCIENCE (2018)
Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug Ratio
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2018)
Direct and quantitative evaluation of the human CYP3A4 contribution (fm) to drug clearance using the in vitro SILENSOMES model
Yannick Parmentier et al.
XENOBIOTICA (2017)
Prediction of the site of CYP3A4 metabolism of tolterodine by molecular dynamics simulation from multiple initial structures of the CYP3A4-tolterodine complex
Atsuko Sato et al.
CHEM-BIO INFORMATICS JOURNAL (2017)
Mechanistic Modeling to Predict Midazolam Metabolite Exposure from In Vitro Data
Hoa Q. Nguyen et al.
DRUG METABOLISM AND DISPOSITION (2016)
Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4
Hitomi Yuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes
Noriaki Yoda et al.
XENOBIOTICA (2012)
Rationalization and prediction of in vivo metabolite exposures: the role of metabolite kinetics, clearance predictions and in vitro parameters
Justin D. Lutz et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
In Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase
Michael Zientek et al.
DRUG METABOLISM AND DISPOSITION (2010)
Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide
Olga L. Zharikova et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Predicting Circulating Human Metabolites: How Good Are We?
Shelby Anderson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites
Deepak Dalvie et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Human CYP2C8: Structure, Substrate Specificity, Inhibitor Selectivity, Inducers and Polymorphisms
Xin-Sheng Lai et al.
CURRENT DRUG METABOLISM (2009)
Issues in the safety testing of metabolites
Gerhard Gross et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Determinants of cytochrome P4502C8 substrate binding -: Structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid
Guillaume A. Schoch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon
Olga L. Zharikova et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Marcella Martignoni et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Structure of human microsomal cytochrome P4502C8 - Evidence for a peripheral fatty acid binding site
GA Schoch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Analysis of human cytochrome P4502C8 substrate specificity using a substrate pharmacophore and site-directed mutants
A Melet et al.
BIOCHEMISTRY (2004)
mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates
MJ Graham et al.
XENOBIOTICA (2003)
Share Paper
